September 4, 2026 / OrthoSpineNews / – The original Cybion®- BFIX® TTT System has been developed to support surgeons treating patients with complex lower limb conditions, particularly where limb preservation and enhanced vascular regeneration are critical treatment objectives. (invented, developed and perfected by Prof. Gang Li, MBBS, D. Phil. (Oxon), FICORS, FORS, and team) across the United States bringing this innovative technology to a wider orthopedic and limb reconstruction community.
The Cybion® TTT System is the only Proven TTT System that has been used in a multitude of successful surgeries globally, including China, Europe, Australia, North and South America. It is the only minimally invasive surgical (MIS) TTT System available, (which can avoid increase stress to the soft tissue envelopeand reduce the risk of potential infection.)
The Cybion® TTT System offers a Powerful solution to improve revascularization and wound healing within an appropriately identified patient cohort that present with ischemic ulcers of the lower limb.
Over five years of successful use and global clinical collaboration, the Cybion GmbH team have developed an optimised treatment Protocol that encompasses pre and post-operative pathways, that have assisted in significantly improving outcomes.
As the only TTT device founded on evidence-based research and supported by clinical findings, the Cybion® TTT System and its philosophy have been refined through years of clinical experience. We are excited to partner with Cybion GmbH to build on the passion, clinical awareness, and understanding of the optimal treatment pathway that Peter Strating and Roman Stauch have worked tirelessly to advance within this sector. For more information about the Cybion® TTT System, please visit www.cybion.de
“The clinical success and the evidence generated internationally with the Cybion® TTT System is undeniable. Launching this into the U.S. is another step towards OrthoSolutions® becoming a leader in Limb Salvage. A huge thank you to both teams whose commitment and collaboration have made this partnership possible. Together, we look forward to advancing limb preservation and improving patient care”
— Eliot Clare, CEO OrthoSolutions
Ortho Solutions Inc. will be exhibiting the Cybion® TTT System at the upcoming AOFAS congress in Seattle – Booth 1037
OrthoSolutions TTT cadaveric lab @AOFAS
Date – 17th September
Venue – Mt. Constance Boardroom, Hilton Garden Inn Downtown, 1821 Boren Ave, Seattle, WA 98101
Time – 7am – 10am
Numbers for this event are strictly limited and need to be pre-booked. Register your interest and secure your seat at us.sales@orthosol.com
About OrthoSolutions®
Established over 24 years ago, OrthoSolutions® Group has become a leader in the Orthopaedic, lower extremity market with a unique and wide-ranging implant product portfolio. We strive to offer and develop evidence based clinical solutions in collaboration with surgeons which ultimately provides patients with a better quality of life.
Our ultimate goal, which we continually strive to achieve, is to help patients, suffering from painful and debilitating lower extremity conditions, to regain their mobility. We believe that our focus helps ensure that we are better able to design improved surgical solutions in partnership with specialist surgeons, which help their patients get back on their feet. For further information on OrthoSolutions®, please visit our website – www.orthosol.com
#OrthoSolutions #Cybion #TransverseTibiaTransport #TTT #LimbSalvage #Orthopaedics #LimbReconstruction #Proven #Powerful #Protocol #MedicalDevices #HealthcareInnovation #PatientCare #SurgeonEducation #Partnerships
